BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 22292789)

  • 1. Herb-drug interactions and mechanistic and clinical considerations.
    Chen XW; Sneed KB; Pan SY; Cao C; Kanwar JR; Chew H; Zhou SF
    Curr Drug Metab; 2012 Jun; 13(5):640-51. PubMed ID: 22292789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical herbal interactions with conventional drugs: from molecules to maladies.
    Chen XW; Serag ES; Sneed KB; Liang J; Chew H; Pan SY; Zhou SF
    Curr Med Chem; 2011; 18(31):4836-50. PubMed ID: 21919844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herb-drug interactions: a literature review.
    Hu Z; Yang X; Ho PC; Chan SY; Heng PW; Chan E; Duan W; Koh HL; Zhou S
    Drugs; 2005; 65(9):1239-82. PubMed ID: 15916450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between herbal medicines and prescribed drugs: a systematic review.
    Izzo AA; Ernst E
    Drugs; 2001; 61(15):2163-75. PubMed ID: 11772128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of metabolism-mediated herb-drug interactions.
    Na DH; Ji HY; Park EJ; Kim MS; Liu KH; Lee HS
    Arch Pharm Res; 2011 Nov; 34(11):1829-42. PubMed ID: 22139684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between herbal medicines and prescribed drugs: an updated systematic review.
    Izzo AA; Ernst E
    Drugs; 2009; 69(13):1777-98. PubMed ID: 19719333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of drugs that interact with herbs in drug development.
    Zhou SF; Zhou ZW; Li CG; Chen X; Yu X; Xue CC; Herington A
    Drug Discov Today; 2007 Aug; 12(15-16):664-73. PubMed ID: 17706549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-herb interactions: eliminating toxicity with hard drug design.
    Yang XX; Hu ZP; Duan W; Zhu YZ; Zhou SF
    Curr Pharm Des; 2006; 12(35):4649-64. PubMed ID: 17168768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical drugs that interact with St. John's wort and implication in drug development.
    Di YM; Li CG; Xue CC; Zhou SF
    Curr Pharm Des; 2008; 14(17):1723-42. PubMed ID: 18673195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
    Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
    Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba.
    Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Cui Y; Ang CY
    Drugs Aging; 2005; 22(6):525-39. PubMed ID: 15974642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters.
    Meng Q; Liu K
    Curr Drug Metab; 2014; 15(8):791-807. PubMed ID: 25705905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interactions between herbal remedies and medicinal drugs.
    Ioannides C
    Xenobiotica; 2002 Jun; 32(6):451-78. PubMed ID: 12160480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.
    Dasgupta A
    Ther Drug Monit; 2008 Apr; 30(2):212-7. PubMed ID: 18367983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herb-drug interactions.
    Fugh-Berman A
    Lancet; 2000 Jan; 355(9198):134-8. PubMed ID: 10675182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperforin in St. John's wort drug interactions.
    Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V
    Eur J Clin Pharmacol; 2006 Mar; 62(3):225-33. PubMed ID: 16477470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction.
    Izzo AA; Di Carlo G; Borrelli F; Ernst E
    Int J Cardiol; 2005 Jan; 98(1):1-14. PubMed ID: 15676159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDR- and CYP3A4-mediated drug-herbal interactions.
    Pal D; Mitra AK
    Life Sci; 2006 Mar; 78(18):2131-45. PubMed ID: 16442130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.